Louis Monnier

Summary

Country: France

Publications

  1. ncbi Contributions of fasting and postprandial glucose to hemoglobin A1c
    Louis Monnier
    Department of Metabolism, Lapeyronie Hospital, Montpellier, France
    Endocr Pract 12:42-6. 2006
  2. ncbi Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, Montpellier, France
    Diabetes Care 25:737-41. 2002
  3. ncbi Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, University of Montpellier, Montpellier, France
    JAMA 295:1681-7. 2006
  4. ncbi Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update
    Antonio Ceriello
    Clinical Science Research Institute, Clinical Science Building, Warwick Medical School, University of Warwick, Coventry, UK
    Nutr Metab Cardiovasc Dis 16:453-6. 2006
  5. ncbi Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom?
    L Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, 34295 Montpellier cedex 05, France
    Diabetes Metab 33:247-52. 2007
  6. ncbi Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire
    Luc Martinez
    French Society of General Medicine, Issy les Moulineaux, France
    Health Qual Life Outcomes 5:53. 2007
  7. ncbi Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes
    L Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, University Institute of Clinical Research, Montpellier, France
    Eur J Clin Invest 36:231-5. 2006
  8. ncbi Type 2 diabetes: a well-characterised but suboptimally controlled disease. Can we bridge the divide?
    L Monnier
    Laboratory of Human Nutrition, University Institute of Clinical Research, 34093 Montpellier Cedex 5, France
    Diabetes Metab 34:207-16. 2008
  9. ncbi Glycemic variability: should we and can we prevent it?
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, 34295 Montpellier Cedex 5, France
    Diabetes Care 31:S150-4. 2008
  10. ncbi The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, 34295 Montpellier Cedex 5, France
    Diabetes Care 30:263-9. 2007

Collaborators

Detail Information

Publications31

  1. ncbi Contributions of fasting and postprandial glucose to hemoglobin A1c
    Louis Monnier
    Department of Metabolism, Lapeyronie Hospital, Montpellier, France
    Endocr Pract 12:42-6. 2006
    ..Postmeal thresholds for predicting good or satisfactory control of diabetes are dependent on the timing of the meals...
  2. ncbi Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, Montpellier, France
    Diabetes Care 25:737-41. 2002
    ..To determine whether, over daytime, one or several hyperglycemic excursions exist that can be general failures in the glycemic control of patients with type 2 diabetes...
  3. ncbi Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, University of Montpellier, Montpellier, France
    JAMA 295:1681-7. 2006
    ..Glycemic disorders, one of the main risk factors for cardiovascular disease, are associated with activation of oxidative stress...
  4. ncbi Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update
    Antonio Ceriello
    Clinical Science Research Institute, Clinical Science Building, Warwick Medical School, University of Warwick, Coventry, UK
    Nutr Metab Cardiovasc Dis 16:453-6. 2006
    ..Therefore, in addition to HbA1c and FPG, physicians should consider monitoring and targeting PPG in patients with type 2 diabetes...
  5. ncbi Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom?
    L Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, 34295 Montpellier cedex 05, France
    Diabetes Metab 33:247-52. 2007
    ....
  6. ncbi Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire
    Luc Martinez
    French Society of General Medicine, Issy les Moulineaux, France
    Health Qual Life Outcomes 5:53. 2007
    ..A better understanding of patients' perception of insulin would eventually help physicians to adopt the most appropriate dialogue when having to motivate patients to initiate or to intensify insulin injection...
  7. ncbi Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes
    L Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, University Institute of Clinical Research, Montpellier, France
    Eur J Clin Invest 36:231-5. 2006
    ..The present study was designed to compare the respective roles of both determinants on HbA1c, in type 2 diabetic patients, according to whether or not residual beta-cell function was stimulated with insulin secretagogues...
  8. ncbi Type 2 diabetes: a well-characterised but suboptimally controlled disease. Can we bridge the divide?
    L Monnier
    Laboratory of Human Nutrition, University Institute of Clinical Research, 34093 Montpellier Cedex 5, France
    Diabetes Metab 34:207-16. 2008
    ....
  9. ncbi Glycemic variability: should we and can we prevent it?
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, 34295 Montpellier Cedex 5, France
    Diabetes Care 31:S150-4. 2008
    ..e., the glucose instability). Particular attention should be paid to such emerging therapeutic agents as the glucagon-like peptide 1 agonists and the dipeptidyl peptidase (DPP)-IV inhibitors that act through the incretin pathway...
  10. ncbi The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, 34295 Montpellier Cedex 5, France
    Diabetes Care 30:263-9. 2007
    ..The aim of the study was to determine whether the loss of fasting and postprandial glycemic control occurs in parallel or sequentially in the evolution of type 2 diabetes...
  11. ncbi Contribution of postprandial glucose to chronic hyperglycaemia: from the "glucose triad" to the trilogy of "sevens"
    L Monnier
    Department of Metabolic Diseases, Hopital Lapeyronie, 34295 Montpellier cedex 05
    Diabetes Metab 32:2S11-6. 2006
    ....
  12. ncbi [Type 1 diabetes of the child and the adult. Type 2 diabetes of the adult. Complications of diabetes]
    Louis Monnier
    , , 34295 Montpellier 5
    Rev Prat 57:653-64. 2007
  13. ncbi Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities
    L Monnier
    Hôpital Lapeyronie Service des maladies métaboliques, 34295 Montpellier Cedex 5, France
    Diabetes Metab 32:7-13. 2006
    ..This stepwise strategy may eventually lead to a standard basal-bolus regimen with 3 pre-meal injections of rapid-acting insulin analogues, a potentially small trade-off for achieving fairly-well controlled diabetes...
  14. ncbi [Pioglitazone insulin sensitivity and type 2 diabetes mellitus: recent data]
    L Monnier
    Service des Maladies Métaboliques, Hopital Lapeyronie, CHU de Montpellier
    Ann Endocrinol (Paris) 65:136-48. 2004
    ....
  15. ncbi An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives
    L Monnier
    Department of Metabolism, Lapeyronie Hospital, 34295 Montpellier Cedex 5, France
    Diabetes Metab 31:101-9. 2005
    ..3%...
  16. ncbi Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept
    Louis Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, Montpellier, France
    Diabetes Metab Res Rev 25:393-402. 2009
    ..This brings together, in a simple, unified concept, the conventional markers (HbA(1c) and fasting glucose) and the more recently recognized markers of glycaemic control (PPG excursions and acute glycaemic variability)...
  17. ncbi Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)
    Louis Monnier
    Department of Metabolism, Lapeyronie Hospital, Montpellier, France
    Diabetes Care 26:881-5. 2003
    ..To test the effect of overall glycemic control itself, we analyzed the diurnal glycemic profiles of type 2 diabetic patients investigated at different levels of HbA(1c)...
  18. ncbi Global assessment for quality and safety of control in type 2 diabetic patients
    L Monnier
    Department of Metabolism, Lapeyronie Hospital, Montpellier Cedex, France
    Eur J Clin Invest 34:37-42. 2004
    ..This study was conducted to discern whether the monitoring of one particular plasma glucose (PG) value of the diurnal profile can be used in such situations...
  19. ncbi Management of French patients with type 2 diabetes mellitus in medical general practice: report of the Mediab observatory
    L Monnier
    Department of Metabolic Diseases, Lapeyronie Hospital, Montpellier, France
    Diabetes Metab 30:35-42. 2004
    ..The Mediab study was conducted to estimate the medical care in French patients with type 2 diabetes mellitus managed by general practitioners on an ambulatory basis, but consIdered as requiring new treatment implementation...
  20. ncbi Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study
    Louis Monnier
    Laboratory of Human Nutrition and Atherogenesis, University Institute of Clinical Research, Montpellier Cedex 5, France
    Diabetes Metab Res Rev 27:348-53. 2011
    ....
  21. ncbi Targeting prandial hyperglycemia: how important is it and how best to do this?
    Louis Monnier
    Laboratory of Human Nutrition, University Institute of Clinical Research, 641 Avenue du Doyen Giraud, 34093 Montpellier Cedex 5, France
    Curr Diab Rep 8:368-74. 2008
    ....
  22. ncbi The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes
    Louis Monnier
    Laboratory of Human Nutrition and Atherosclerosis, Institute of Clinical Research of Montpellier I, Montpellier, France
    Diabetes Technol Ther 13:813-8. 2011
    ..The present study was designed to define the relative contributions of glucose variability and ambient glycemia to the incidence of asymptomatic hypoglycemia in type 2 diabetes...
  23. ncbi Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T Trials
    Louis Monnier
    University of Montpellier I, Institute of Clinical Research, 641 Avenue du Doyen Giraud, 34093 Montpellier Cedex 5, France
    Expert Opin Pharmacother 9:2857-65. 2008
    ..Two studies, the Apollo and 4-T Trials, were conducted in order to determine which insulin regimen (basal or prandial) is the most efficient for the treatment of insulin-requiring type 2 diabetic patients...
  24. ncbi Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts
    Louis Monnier
    Laboratory of Human Nutrition and Atherosclerosis, Institute of Clinical Research, University of Montpellier I, Montpellier, France
    Diabetes Technol Ther 13:S25-32. 2011
    ..This key feature clearly depicts the absolute contribution of PPG in contrast to its relative contribution and better explains why PPG contributes to the excess of glycation with the basal hyperglycemia...
  25. ncbi Guideline for management of postmeal glucose
    Antonio Ceriello
    Warwick Medical School, Clinical Science Research Institute, Clinical Science Building, University Hospital Walsgrave Campus, Clifford Bridge Road, Coventry CV2 2DX, UK
    Nutr Metab Cardiovasc Dis 18:S17-33. 2008
    ..This guideline reviews the evidence on the harmful effects of elevated postmeal glucose and makes recommendations on its treatment, assessment and targets...
  26. ncbi Postprandial glucose regulation: new data and new implications
    Lawrence A Leiter
    St Michael s Hospital, University of Toronto, Toronto, Canada
    Clin Ther 27:S42-56. 2005
    ..However, physicians continue to rely on fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) to guide management...
  27. ncbi Postprandial glucose regulation and diabetic complications
    Antonio Ceriello
    Department of Pathology and Medicine Experimental and Clinical, University of Udine, Udine, Italy
    Arch Intern Med 164:2090-5. 2004
    ..The present review examines the hypothesis that controlling postprandial glucose level is an important strategy in the prevention of cardiovascular complications associated with diabetes...
  28. ncbi The effect of glucose variability on the risk of microvascular complications in type 1 diabetes
    Louis Monnier
    Diabetes Care 30:185-6; author reply 187-8. 2007
  29. ncbi Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells
    Cristina De Oliveira
    ,
    J Lab Clin Med 145:144-50. 2005
    ..These data may help justify current therapeutic approaches involving the use of insulin and PPAR-gamma agonists...
  30. ncbi Inflammatory parameters are independent predictors of severe epicardial coronary stenosis in asymptomatic diabetic patients with silent myocardial ischemia
    Christophe Piot
    Cardiovascular Diseases Department, Montpellier University Hospital, France
    Diabetes Care 26:545-6. 2003
  31. ncbi Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats
    Cristina de Oliveira Silva
    Laboratoire de Nutrition Humaine et Athérogénèse LNHA, EA 2993, Institut Universitaire de Recherche Clinique, Universite Montpellier I, 641 Avenue du Doyen Giraud, 34093 Montpellier, France
    Nutr Metab Cardiovasc Dis 18:23-30. 2008
    ..The context of overexpression of CD36 in aortas was also evaluated...